← back to search

Robin Guo

Nanjing Medical University · US
Area of research
Pulmonary and Respiratory Medicine · Hepatology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Liver physiology and pathology, Endometrial and Cervical Cancer Treatments, and Chromatin Remodeling and Cancer.
h-index
15
citations
1,166
works
49
NIH funding
primary concept
Medicine
email

Recent publications

MET-dependent solid tumours — molecular diagnosis and targeted therapy
Nature Reviews Clinical Oncology 2020cited by 313position: firstdoi
Characterization of on-target adverse events caused by TRK inhibitor therapy
Annals of Oncology 2020cited by 86position: middledoi
<i>MET</i> Exon 14–altered Lung Cancers and MET Inhibitor Resistance
Clinical Cancer Research 2020cited by 78position: firstdoi
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium
Journal of Thoracic Oncology 2019cited by 174position: firstdoi
Immunophenotype and Response to Immunotherapy of <i>RET</i>-Rearranged Lung Cancers
JCO Precision Oncology 2019cited by 117position: middledoi
Response to Selective RET Inhibition With LOXO-292 in a Patient With <i>RET</i> Fusion-Positive Lung Cancer With Leptomeningeal Metastases
JCO Precision Oncology 2019cited by 42position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Alexander Drilon · Université Grenoble Alpes6 papers (2019–2020)Natasha Rekhtman · Kettering University4 papers (2019–2020)Mark G. Kris · Kettering University4 papers (2019–2020)Maria E. Arcila · Molecular Oncology (United States)3 papers (2019–2020)Michael Offin · RIKEN BioResource Research Center3 papers (2019–2020)Bob T. Li · Presbyterian Hospital3 papers (2019–2020)Jason C. Chang · Memorial Sloan Kettering Cancer Center2 papers (2019–2020)David M. Hyman · Mayo Clinic in Florida2 papers (2019–2020)Ryma Benayed · AstraZeneca (United States)2 papers (2019–2020)Christina J. Falcon · Center for Cancer Research2 papers (2020–2020)Charles M. Rudin · New York Proton Center2 papers (2019–2020)Dara L. Aisner · University of Colorado Cancer Center1 papers (2019–2019)Ai Ni · Center for Drug Evaluation and Research1 papers (2019–2019)Bruce E. Johnson · Zhejiang University1 papers (2019–2019)Gregory J. Riely · Weill Cornell Medicine1 papers (2019–2019)Andrew Chow · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2020–2020)James J. Harding · Florida State University1 papers (2020–2020)Gopa Iyer · New York Proton Center1 papers (2020–2020)Paul A. Bunn · University of Colorado Denver1 papers (2019–2019) · 1 papers (2019–2019)